Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Both vitamin C 20% and tranexamic acid 5mg/ml combined with microneedling were used for treatment of periorbital hyperpigmentation in a comparative pattern and both resulted in significant improvement of periorbital hyperpigmentation by dermoscopic and clinical evaluation with no statistically significant difference between them in addition to improvement of patients' visual analogue score (VAS) and dermatology life quality index (DLQI).
Sixty patients with periorbital hyperpigmentation were enrolled, patients were divided into 2 groups; 30 each. clinical grading according to sheth et al.,2014 , dermoscopic evaluation, visual analogue score (VAS) and DLQI were done at week 0. Group A one side was treated with vit.c 20% + microneedling, other side saline+ microneedling (placebo). group B one side was treated with tranexamic acid 5mg/ml + microneedling, other side saline+ microneedling (placebo). A total of 4 sessions were done 2 weeks apart and follow up was one month after the last session (week 10) at which patient was evaluated using above mentioned parameters in addition to evaluation by 2 blinded investigators. At week 10 there was significant improvement of clinical grading and as evaluated by blinded investigators, VAS, DLQI, significant dermoscopic improvement in both vascular and pigmentary components of dark halos in sides treated with vit c and tranexamic acid compared to placebo but there was no statistically significant difference between both groups. The study concluded that tranexamic acid is a new safe effective modality in treatment of periorbital hyperpigmentation with results comparable to vitamin C.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| group A | Experimental | one eye was treated with vitamin c 20% + microneedling a session was done every 2 weeks a total of 4 sessions (other eye was placebo treated with saline + microneedling). |
|
| group B | Experimental | one eye was treated with tranexamic acid 5 mg/ml + microneedling a session was done every 2 weeks a total of 4 sessions (other eye was placebo treated with saline + microneedling). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| vitamin c 20% | Drug | one eye was treated with vitamin c 20% + microneedling a session was done every 2 weeks a total of 4 sessions (other eye was placebo treated with saline + microneedling). |
| Measure | Description | Time Frame |
|---|---|---|
| evaluation of effectiveness of tranexamic acid in periorbital hyperpigmentation | this is evaluated using dermoscopy (giving a score from 0 to 4, 0 = no improvement, 1=1-25% improvement, 2 =26- 50% improvement, 3=51-75% improvement, 4=>75% improvement) | 10 weeks (patients are assissed 1 month after the last session) |
| evaluation of effectiveness of tranexamic acid in periorbital hyperpigmentation | clinical improvement by two blinded investigators (giving a score from 0 to 4, 0 = no improvement, 1=1-25% improvement, 2 =26- 50% improvement, 3=51-75% improvement, 4=>75% improvement) | 10 weeks (patients are assissed 1 month after the last session) |
| evaluation of effectiveness of tranexamic acid in periorbital hyperpigmentation | clinical improvement by physician (grade from 0 to 4 according to sheth et al.,2014 where 0 no halos and 4 most severe) | 10 weeks (patients are assissed 1 month after the last session) |
| evaluation of effectiveness of tranexamic acid in periorbital hyperpigmentation | dermatology life quality index (score from 0 to 30 the higher the worst) | 10 weeks (patients are assissed 1 month after the last session) |
| evaluation of effectiveness of tranexamic acid in periorbital hyperpigmentation | patient visual analogue score (score from 0 to 10 the higher the worst) | 10 weeks (patients are assissed 1 month after the last session) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Doaa Mohsen | Giza | Egypt |
im looking forward sharing the data but i have no plan yet
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001205 | Ascorbic Acid |
| D014148 | Tranexamic Acid |
| ID | Term |
|---|---|
| D013400 | Sugar Acids |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
Not provided
Not provided
clinical trial, patients were divided into two groups, 30 each.
Not provided
Not provided
blinded investigators that assess grade of improvement at end of the study compared to baseline
|
| Tranexamic acid 5mg/ml | Drug | one eye was treated with tranexamin acid 5 mg/ml + microneedling a session was done every 2 weeks a total of 4 sessions (other eye was placebo treated with saline + microneedling) |
|
|
| D006880 |
| Hydroxy Acids |
| D002241 | Carbohydrates |
| D003509 | Cyclohexanecarboxylic Acids |
| D000146 | Acids, Carbocyclic |